Probiotic Bacterial Molecule-Based Solutions for Diverse Industries

Publication ID: 24-11857581_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Probiotic Bacterial Molecule-Based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857581_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857581_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,581.

Summary of the Inventive Concept

This inventive concept leverages the antiviral properties of probiotic bacterial molecules to develop novel solutions for reducing viral contamination and transmission in various industries, including wastewater treatment, agriculture, food processing, animal husbandry, and recreational water sources.

Background and Problem Solved

The original patent disclosed the use of probiotic bacterial molecules for controlling pathogenic viruses in mammals. However, the patent's scope was limited to medical applications. The present inventive concept addresses the need for innovative solutions to tackle viral contamination in diverse industries, where existing methods are often ineffective or inadequate.

Detailed Description of the Inventive Concept

The new inventive concept involves the application of probiotic bacterial molecule-based treatments to various industries, including: 1) industrial wastewater treatment to minimize viral contamination; 2) agricultural soil to reduce viral infections in plants and improve crop yields; 3) food processing facilities to reduce viral contamination on surfaces and equipment; 4) animal husbandry to reduce viral transmission through animal feed and water; and 5) recreational water sources to minimize viral contamination. These treatments utilize the antiviral properties of probiotic bacterial molecules, which have been shown to be effective against various viruses.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift by applying the core technology of the original patent to entirely new industries and use cases, thereby providing a novel and non-obvious solution to the problem of viral contamination. The inventive step lies in the recognition of the potential of probiotic bacterial molecules to address viral contamination in diverse industries, and the development of tailored solutions for each industry.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different probiotic bacterial strains, varying concentrations of probiotic bacterial molecules, or combination therapies with other antiviral agents. Variations of the inventive concept may also involve the development of probiotic bacterial molecule-based treatments for other industries, such as textiles or cosmetics.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential, as it addresses a pressing need for effective solutions to viral contamination in various industries. The target markets include wastewater treatment facilities, agricultural companies, food processing industries, animal husbandry businesses, and recreational water source management companies. The potential market size is substantial, with opportunities for licensing, partnerships, and product sales.

Original Patent Information

Patent NumberUS 11,857,581
TitleAntiviral methods and compositions comprising probiotic bacterial molecules
Assignee(s)MICROSINTESIS INC.